Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA)-Reference-Cited by-同舟云学术

Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA)

Published:2018-09 Issue:3 Volume:11 Page:187-188
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Mukherjee Sarbajit,Ayanambakkam Adanma,Ibrahimi Sami,Schmidt Sarah,Charkrabarty Jennifer Holter,Khawandanah Mohamad

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference6 articles.

1. Development of human anti-murine antibody (HAMA) response in patients;Tjandra;Immunol Cell Biol,1990

2. Jankowitz et al. Anaphylaxis after administration of ibritumomab tiuxetan for follicular non-Hodgkin lymphoma. Clin Nucl Med 2008;33(2):94–6.

3. Mirick et al. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Q J Nucl Med Mol Imaging 2004;48(4):251–7.

4. Goldenberg et al. The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy. Crit Rev Oncol/Hematol 2001;39(1–2).

5. Witzig et al. Safety of ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin’s lymphoma. J of Clin Oncol 2003;21(7).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropathological implication of high blood bilirubin in patients and model rats with depression;Brain Research Bulletin;2024-09

2. Use of monoclonal antibodies in cancer immunotherapy: types and mechanisms of action;Boletín Médico del Hospital Infantil de México;2023-07-17

3. KANSER TANISI VE TEDAVİSİNDE KULLANILAN MONOKLONAL ANTİKORLAR;Ankara Universitesi Eczacilik Fakultesi Dergisi;2023-01-31

4. Pharmacokinetic Study of Antibody-Drug Conjugates;Antibody-Drug Conjugates and Cellular Metabolic Dynamics;2023

5. Protein and Peptide-Based Therapeutics for Cancer Imaging;Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications;2022